This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seegmüller, I.
Right arrow Articles by Reinert, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seegmüller, I.
Right arrow Articles by Reinert, R. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2007, p. 666-667, Vol. 45, No. 2
0095-1137/07/$08.00+0     doi:10.1128/JCM.01774-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Globicatella sanguinis Is an Etiological Agent of Ventriculoperitoneal Shunt-Associated Meningitis{triangledown}

I. Seegmüller,* M. van der Linden, C. Heeg, and R. R. Reinert

German National Reference Centre for Streptococci, Institute for Medical Microbiology, RWTH Aachen, Pauwelsstr. 30, D-52074 Aachen, Germany

Received 28 August 2006/ Returned for modification 11 October 2006/ Accepted 8 November 2006


arrow
ABSTRACT
 
Globicatella sanguinis is a very rare isolate in clinical samples. We present a case of meningitis in a 69-year-old female patient after implantation of an external left ventricular drainage due to a hydrocephalus. She recovered after antibiotic treatment with ceftriaxone.


arrow
CASE REPORT
 
In October 2005 a 69-year-old female patient presented with a 1-year history of worsening weakness of her left leg and left arm and increasing problems with walking. She complained of being confused sometimes. Additionally, she had a longstanding history of depressive disorders for which she had been in psychiatric care for several years.

A computed tomography brain scan showed a dilated ventricular system, and the preliminary diagnosis of normal-pressure hydrocephalus was made. To confirm the diagnosis and to assess the suitability of the implantation of a ventriculoperitoneal shunt, an external left ventricular drainage was implanted on 26 October 2005. The diagnosis could be confirmed, and the drainage was removed on 28 October 2005. In the morning of 30 October 2005 the patient was somnolent, threw up several times, and presented clinical signs of meningitis. A control computed tomography scan showed an unchanged ventricular configuration. The differential diagnosis of decompensated hydrocephalus or infectious meningitis was made, and a new external ventricular drainage was implanted. In a sample of cerebrospinal fluid, lactate levels were elevated to 6.35 mmol/liter, and subsequently a gram-positive coccus was grown. The patient was put on intravenous ceftriaxone (2 g once daily for 10 days) and improved rapidly. After negative cerebrospinal fluid cultures, a definitive ventriculoperitoneal shunt was implanted on 9 November 2005. On the 22 November the patient was transferred to a specialized rehabilitation facility.

The culture of the first cerebrospinal fluid sample (Columbia agar supplemented with 5% sheep blood and pyridoxal, 37°C, 5%CO2) resulted in faint growth of rough, alpha-hemolytic colonies after 24 h, which was more pronounced after 48 h (Fig. 1). Gram staining showed a gram-positive coccus (short chains). A catalase test was negative. An optochin test (5-µg disk; Oxoid) was negative (no inhibition zone). The rapid ID32strep test resulted in the finding of a Globicatella sp. The Phoenix system (PMIC/ID-56) confirmed the API result and identified the bacterium as Globicatella sanguinis (certainty of 99%). Surprisingly, a 16S rRNA sequence analysis showed 99% identity with the 16S rRNA sequence of G. sulfidifaciens (GenBank accession no. AJ297627) and 95% identity with the16S rRNA sequence of G. sanguinis (GenBank accession no. S50214).


Figure 1
View larger version (158K):
[in this window]
[in a new window]

 
FIG. 1. Globicatella sanguinis (48 h of growth, CO2, 37°C, Columbia agar supplemented with 5% sheep blood and pyridoxal).

Looking into the literature, we found that the biochemical profile of G. sanguinis is based on a total of 29 isolates (1a, 3). The biochemical profile of G. sulfidifaciens is based on a total of eight isolates (7). Of 33 reactions for our isolate, only one was not in line with G. sanguinis, but six reactions were not in line with G. sulfidifaciens, one of which is the production of sulfide (Table 1). In the original publication (7), the authors stressed the importance of this parameter for the differentiation between G. sanguinis (negative) and G. sulfidifaciens (positive). Our isolate is negative. On the other hand, there is only one 16S rRNA sequence for each Globicatella sp. in GenBank. Additionally, these sequences are very similar, and there is evidence that currently the database for the identification of Globicatella spp. based on 16S rRNA is too small to be helpful (2). Therefore, we named our isolate G. sanguinis in accordance with the biochemical profile.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Differences in biochemical profiles of G. sulfidifaciens, G. sanguinis, and our straina

Antimicrobial susceptibility testing was done according to the 2005 CLSI guidelines (1), using the established breakpoints for Streptococcus spp. other than S. pneumoniae. Broth microdilution was performed for penicillin G, cefotaxime, clarithromycin, clindamycin, tetracycline, telithromycin, gatifloxacin, and levofloxacin. MICs of vancomycin, linezolid, imipenem, erythromycin, and ciprofloxacin were determined using the Etest. The results are shown in Table 2.


View this table:
[in this window]
[in a new window]

 
TABLE 2. MICs

There are two well-known mechanisms for macrolide resistance. The presence of the mef gene is associated with macrolide-only resistance, whereas the ermB gene causes combined macrolide/lincosamide resistance. There are no published reports on the origin of macrolide resistance in Globicatella isolates. To investigate the resistance mechanism in our isolate, a mef PCR and an ermB PCR were performed (4, 5). The mef PCR was positive, whereas the ermB PCR was negative. These results confirm the macrolide resistance and the lincosamide sensitivity of our isolate.

G. sanguinis was first described in 1992 by Collins and coworkers, who named it G. sanguis (1a). It was renamed G. sanguinis in 1997 by Trüper and de'Clari (6). A PubMed search for Globicatella revealed that G. sanguinis was described as a cause of meningoencephalitis in lambs by Vela and coworkers in 2000 (8). Whether our patient had contact with sheep could not be elucidated. In 2001, Shewmaker and coworkers (3) published the first susceptibility testing results for G. sanguinis, which are in good accordance with our own results. Interestingly, 48% of their 27 strains showed resistance to cefotaxime, with a MIC50 of 1.0 mg/liter and a MIC90 of 4.0 mg/liter. Fortunately for our patient, our isolate was susceptible to cefotaxime.


arrow
ACKNOWLEDGMENTS
 
We thank B. Weidenhaupt for excellent laboratory work.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: German National Reference Centre for Streptococci, Institute for Medical Microbiology, RWTH Aachen, Pauwelsstr. 30, D-52074 Aachen, Germany. Phone: 49/241-80-35632. Fax: 49/241-80-82483. E-mail: iseegmueller{at}ukaachen.de. Back

{triangledown} Published ahead of print on 22 November 2006. Back


arrow
REFERENCES
 
    1
  1. CLSI. 2005. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. M100-S15. CLSI, Wayne, Pa.
  2. 1
  3. Collins, M. D., M. Aguirre, R. R. Facklam, J. Shallcross, and A. M. Williams. 1992. Globicatella sanguis gen.nov., sp.nov., a new gram-positive catalase-negative bacterium from human sources. J. Appl. Bacteriol. 73:433-437.[Medline]
  4. 2
  5. Lau, S. K., P. C. Woo, N. K. Li, J. L. Teng, K. W. Leung, K. H. Ng, T. L. Que, and K. Y. Yuen. 2006. Globicatella bacteraemia identified by 16S ribosomal RNA gene sequencing. J. Clin. Pathol. 59:303-307.[Abstract/Free Full Text]
  6. 3
  7. Shewmaker, P. L., A. G. Steigerwalt, L. Shealey, R. Weyant, and R. R. Facklam. 2001. DNA relatedness, phenotypic characteristics, and antimicrobial susceptibilities of Globicatella sanguinis strains. J. Clin. Microbiol. 39:4052-4057.[Abstract/Free Full Text]
  8. 4
  9. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.[Abstract]
  10. 5
  11. Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res. 18:3660.[Free Full Text]
  12. 6
  13. Trüper, H. G., and L. de'Clari. 1997. Taxonomic note: necessary correction of specific epithets formed as substantives (nouns) "in apposition." Int. J. Syst. Bacteriol. 47:908-909.[Abstract/Free Full Text]
  14. 7
  15. Vandamme, P., J. Hommez, C. Snauwaert, B. Hoste, I. Cleenwerck, K. Lefebvre, M. Vancanneyt, J. Swings, L. A. Devriese, and F. Haesebrouck. 2001. Globicatella sulfidifaciens sp. nov., isolated from purulent infections in domestic animals. Int. J. Syst. Evol. Microbiol. 51:1745-1749.[Abstract]
  16. 8
  17. Vela, A. I., E. Fernandez, A. las Heras, P. A. Lawson, L. Dominguez, M. D. Collins, and J. F. Fernandez-Garayzabal. 2000. Meningoencephalitis associated with Globicatella sanguinis infection in lambs. J. Clin. Microbiol. 38:4254-4255.[Abstract/Free Full Text]


Journal of Clinical Microbiology, February 2007, p. 666-667, Vol. 45, No. 2
0095-1137/07/$08.00+0     doi:10.1128/JCM.01774-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seegmüller, I.
Right arrow Articles by Reinert, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seegmüller, I.
Right arrow Articles by Reinert, R. R.